✦ LIBER ✦

Dopaminergic agonist Ro 8–4650 in Parkinson's disease : I. PATIENTS TREATED WITH DOPA

✍ Scribed by Erik Birket-Smith; Jette BØttcher; Erik Dupont; Per Holm; John P. A. Jensen; Ole Kristensen; Ole KØhler; Bent Mikkelsen

Book ID: 114780734
Publisher: John Wiley and Sons
Year: 2009
Tongue: English
Weight: 143 KB
Volume: 58
Category: Article
ISSN: 0001-6314
DOI: 10.1111/j.1600-0404.1978.tb02862.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Dopaminergic agonist Ro 8–4650 in Parkin

Dopaminergic agonist Ro 8–4650 in Parkinson's disease : II. PATIENTS NOT TREATED WITH DOPA

✍ Jan Presthus; JØrgen Ankerhus; Andrew Burén; Jette BØttcher; Robert Holmsen; Ben 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 157 KB

Impaired transmethylation potential in P

Impaired transmethylation potential in Parkinson's disease patients treated with l-Dopa

✍ Maria Luigia De Bonis; Alessandro Tessitore; Maria Teresa Pellecchia; Katia Long 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 276 KB

Acoustic voice analysis in patients with

Acoustic voice analysis in patients with Parkinson's disease treated with dopaminergic drugs

✍ Javier Gamboa; Félix Javier Jiménez-Jiménez; Alberto Nieto; Jose Montojo; Miguel 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 609 KB

Impulsive smoking in a patient with Park

Impulsive smoking in a patient with Parkinson’s disease treated with dopamine agonists

✍ Karina L. Bienfait; Matthew Menza; Margery H. Mark; Roseanne D. Dobkin 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 111 KB

Plasma homocysteine levels in L-dopa-tre

Plasma homocysteine levels in L-dopa-treated Parkinson's disease patients with cognitive dysfunctions

✍ Zoccolella, Stefano; Lamberti, Paolo; Iliceto, Giovanni; Diroma, Cosimo; Armenis 📂 Article 📅 2005 🏛 Walter de Gruyter GmbH & Co. KG 🌐 English ⚖ 73 KB

Simultaneous MAO-B and COMT inhibition i

Simultaneous MAO-B and COMT inhibition in L-dopa-treated patients with parkinson's disease

✍ Dr. Jukka Lyytinen; Seppo Kaakkola; Sirpa Ahtila; Päivi Tuomainen; Heikki Terävä 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 801 KB

## Abstract The effect of selegiline (L‐deprenyl) on plasma catecholamines, clinical response, and drug tolerability was studied in 13 patients with Parkinson's disease (PD) treated with L‐Dopa/benserazide and entacapone, a peripheral catechol‐__O__‐methyltransferase (COMT) inhibitor, in a placebo‐